The Dell Medical School is the graduate medical school of The University of Texas at Austin in Austin, Texas. The school opened to the inaugural class of 50 students in the summer of 2016 as the newest of 18 colleges and schools on the UT Austin campus.

During the past decade, Dell Medical School, UT-Austin conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 1 clinical trials were completed, i.e. on average, 8.3% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 1 clinical trials were completed. i.e. 10% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Dell Medical School, UT-Austin" #1 sponsor was "University of Texas at Austin" with 5 trials, followed by "Arena Pharmaceuticals" with 1 trials sponsored, "Avita Medical" with 1 trials sponsored, "Pfizer" with 1 trials sponsored and "Population Health Research Institute" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Dell Medical School, UT-Austin" #1 collaborator was "University of Texas at Austin" with 2 trials as a collaborator, "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator, "Juvenile Diabetes Research Foundation" with 1 trials as a collaborator, "Merck Sharp & Dohme LLC" with 1 trials as a collaborator and "Prolacta Bioscience" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Dell Medical School, UT-Austin" are "Ulcerative Colitis" (3 trials), "Crohn Disease" (2 trials), "Inflammatory Bowel Diseases" (2 trials), "Atrial Fibrillation" (1 trials) and "Crohn's Disease" (1 trials). Many other conditions were trialed in "Dell Medical School, UT-Austin" in a lesser frequency.

Most popular intervention types in "Dell Medical School, UT-Austin" are "Other" (8 trials), "Drug" (4 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Etrasimod" (2 trials), "NO INTERVENTION" (2 trials), "Placebo" (2 trials), "After COVID-19 Pandemic" (1 trials) and "During COVID-19 Pandemic" (1 trials). Other intervention names were less common.

The vast majority of trials in "Dell Medical School, UT-Austin" are 10 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are 7 active trials in "Dell Medical School, UT-Austin". 1 are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 2 completed trials in Dell Medical School, UT-Austin, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Dell Medical School, UT-Austin, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".